ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 550

Differences in the Prevalence of Inflammatory Articular Disease in Psoriatic Patients, Applying Clinical, Ultrasound and/or Radiological Data. Implications in the Classification of Psoriatic Arthritis according to Caspar Criteria

Jose Luis Fernandez-Sueiro1, S. Pertega-Diaz2, JA Pinto1 and E. Gonzalez3, 1Rheumatology Division, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 2Epidemiology and Statistics, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 3Rheumatology, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Classification criteria and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose:

a)     To determine differences in the prevalence of inflammatory articular disease (IAD) in patients with cutaneous psoriasis when applying clinical, ultrasound (PDUS) or radiological diagnostic criteria.

b)     To determine the prevalence of PsA in these patients, applying different definitions for the initial stem of the CASPAR criteria, and to compare this prevalence with that based on clinical judgment.

Methods:

Descriptive, observational, cross-sectional study of 122 patients referred from the primary care with a confirmed diagnosis of cutaneous psoriasis, without arthritis.

For the diagnosis of IAD, the following criteria were used:

Peripheral arthritis: a) Clinical (TJC>0 or SJC>0 (78/76)), b) PDUS (carpal, MCP, PIP, MTsP, carpal tendons, hands, feet tendons), c) Radiological (hands and/or feet erosions).

Spine: a) Clinical (inflammatory back pain (IBP) (4/5) and/or nocturnal and VAS overall spinal pain past week >5, b) Radiological (sacroiliitis grade II unilateral or higher).

Entheseal: a) Clinical (MASES plus lateral and medial epycondile, quadriceps tendon, proximal and distal patella, plantar aponeuroses). b) PDUS (lateral and medial epycondile, quadriceps tendon, proximal and distal patella, aquilles tendon plantar aponeuroses)

Prevalence of IAD was obtained, according to different definitions. PsA prevalence was also determined according to CASPAR criteria and clinical judgement. Agreement was evaluated by the Kappa’s index.

Results:

Criteria for peripheral arthritis: clinical criteria 12 (9.8%), PDUS 16 (15%) and erosions 20 (19%). Of 122 patients, 41 (41.4%) met at least one of the criteria for peripheral arthritis. None of them met all three criteria.

Criteria for spinal disease: IBP 8 (12.3%), VAS overall spinal pain in the past week>5 22 (18%), unilateral sacroiliitis grade II or higher 17 (15.5%). Of the patients studied, 5 (4.4%) met the radiological criteria plus one of the clinical criteria. None of them met the 3 criteria altogether.

Criteria for entheseal disease: clinical 13 (10.7%), PDUS 40 (32.8%). Of the 122 patients, 45 (36.9%) met one of this two criteria, 8 patients met both of them.

Prevalence of inflammatory articular disease, based on clinical criteria, was 44.2% (95% CI: 33.1%-52.3%). By combining clinical, ultrasound and radiological results, the prevalence was 61.8% (95% CI: 51.8%-71.7%).

Using only clinical criteria for the diagnosis of inflammatory articular disease, PsA prevalence according to CASPAR criteria was 27.2% (95% CI: 16.9%-37.5%). Combining clinical, ultrasound and radiological criteria, the prevalence was 34.7% (95% CI: 24.6%-44.8%). Only 12 (9.8%) of the patients had PsA according to clinical judgment. Agreement between clinical judgment and CASPAR criteria was low, both when clinical criteria (Kappa=0.247) or clinical+ultrasound+radiologic criteria (Kappa=0.140) were used to define IAD.

Conclusion:

The prevalence of PsA in patients with psoriasis varies from 27.2% to 34.7%, according to the definition of the initial stem in CASPAR criteria. On the other hand, only 9.8% were diagnosed of PsA based on clinical judgment. These data suggest the need for clarifying the stem definition of CASPAR criteria.

*Grant from the Ministery of Health PI080789


Disclosure:

J. L. Fernandez-Sueiro,
None;

S. Pertega-Diaz,
None;

J. Pinto,
None;

E. Gonzalez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differences-in-the-prevalence-of-inflammatory-articular-disease-in-psoriatic-patients-applying-clinical-ultrasound-andor-radiological-data-implications-in-the-classification-of-psoriatic-arth/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology